CNPLaw LLP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Deals and cases


CNPLaw LLP acts as Singapore counsel to the Link Healthcare Group on its acquisition by Clinigen Plc.

Date Published: 3 November 2015

The Team Advising on The Case:  Bill Jamieson and Amit Dhume.


CNPLaw LLP (“CNP”), formerly known as Colin Ng & Partners LLP, acted as Singapore counsel for Link Healthcare (“Link“), a specialist pharmaceutical and medical technology business focussed on the Asian, African and Australasian (“AAA“) regions, on the sale of Link to Clinigen Group plc (“Clinigen“), the speciality global pharmaceutical company listed in the UK, for an initial consideration of £44.5 million and a maximum of approximately £100 million based on achievement of milestones.

Clinigen agreed to acquire Link in late September 2015 and the acquisition was completed on 30 October 2015.


CNPLaw’s Mergers and Acquisitions Lawyers

Bill Jamieson is a Partner at CNPLaw LLP. Bill is an English lawyer who is also registered to practise Singapore law in the areas of corporate law, banking and finance and securities laws. He enjoys working in the diverse and dynamic Asian market and helping his clients to achieve their goals.

    Bill’s practice focuses on corporate financing transactions, investment funds, mergers and acquisitions, private equity, and employment law matters. His experience includes 10 years in the City of London and over 20 years in Asia. Before joining CNP, Bill was a partner in a well-known international law firm. He is recommended lawyer for Corporate and M&A, Banking and Finance, Investment Funds and Labour and Employment in Legal 500 Asia Pacific 2021. Bill is one of the firm’s contacts for Interlaw, a network of independent full-service corporate law firms ranked by Chambers and Partners in its highest category, “Elite”, amongst all global law firm networks.

    Amit Dhume Partner at CNPLaw LLP

      Amit’s practice focuses on corporate law, investment funds, mergers and acquisitions and regulatory and compliance matters. He has over 15 years’ experience in these areas of law. Amit’s expertise has been recognised in Legal 500 Asia Pacific, 2021 as a Recommended Lawyer for Corporate and M&A as well as Investment Funds. In December 2016, Amit was named by Singapore Business Review as one of the 70 most influential lawyers in Singapore under the age of 40.

      Having handled transactions for numerous local and foreign companies across Asia, extending across a wide range of businesses and industries, we have accumulated significant experience advising on an extensive range of corporate finance transactions.

        Mergers and Acquisitions   >  Deals   >   Current Page